The All India Institute of Medical Science-New Delhi has published a tender for "Purchase of Drugs/ Medicines/ Nutritional supplements for Rare Disease/other entitled beneficiaries on 02 years rate contract basis" on the 12 May 2026. This tender belongs to Medicines category. This tender is published in New Delhi, Delhi location. The vendors interested in this tender and related Medicines tenders can obtain further details by exploring Tendersniper web portal. Tendersniper sends regular tender alerts by email specifically addressing the user requirements (i.e., keywords, location and value range). Government business is a growing area of opportunity. The businesses are encouraged to actively monitor tender opportunities and participate in them to grow their business.
Related alert: hospital supply Tenders | pharmacy medicines Tenders | all types of buoys Tenders
Around 8688 tenders were floated in Delhi in the past month with major spending on pipe laying Tenders, ink cartridges Tenders, vehicle hiring Tenders
| Tender Title | Purchase of Drugs/ Medicines/ Nutritional supplements for Rare Disease/other entitled beneficiaries on 02 years rate contract basis |
|---|---|
| Tender Description | RARE DISEASE MEDICINE Inj. Nusinersen 12mg/5ml Cap. Trientine 250mg capsule Tab. Everolimus 2.5mg Tab. Everolimus 7.5mg Tab. Ruxolitinib 05 mg Cap. Eliglustat 84mg Inj. Olipudase alfa-rpcp 20mg Cap. Nitisinone 2mg Cap. Selumetinib 10mg Cap. Selumetinib 25mg Inj. Eculizumab 300mg Inj. Emicizumab 60mg/0.4ml Cap. Diazoxide(1 cap.=25mg) Sodium Phenyl Butyrate Powder- For Urea cycle disorders Tab. Alpelisib (50mg) Tab. Trametinib 0.5 mg Tab. Trametinib 1 mg Tab. Trametinib 2 mg Inj. Imiglucerase 400 units/vial Inj. Velaglucerase alpha-VPRIV 400 units Inj. Laronidase 2.9mg/5ml Inj. Idursulfase 6mg/3ml Inj. Alglucosidase Alfa 50mg Inj. Agalsidasealfa 3.5mg/3.5ml Inj. Agalsidase beta 35mg Syp. Risdiplam 60mg/80ml Cap. Nitisinone 5mg Cap. Nitisinone 10mg Cap. Trientine 333mg Inj. Complement C1 esterase inhibitor 500IU Tab. Everolimus 0.25mg Tab. Everolimus 0.5mg Tab. Everolimus 0.75mg Tab. Everolimus 5mg Tab. Everolimus 10mg Inj. Evolocumab 140mg/ml Inj. Brentuximab 50mg Tab. Tucatinib 150m |
| Comments | RARE DISEASE MEDICINE Inj. Nusinersen 12mg/5ml Cap. Trientine 250mg capsule Tab. Everolimus 2.5mg Tab. Everolimus 7.5mg Tab. Ruxolitinib 05 mg Cap. Eliglustat 84mg Inj. Olipudase alfa-rpcp 20mg Cap. Nitisinone 2mg Cap. Selumetinib 10mg Cap. Selumetinib 25mg Inj. Eculizumab 300mg Inj. Emicizumab 60mg/0.4ml Cap. Diazoxide(1 cap.=25mg) Sodium Phenyl Butyrate Powder- For Urea cycle disorders Tab. Alpelisib (50mg) Tab. Trametinib 0.5 mg Tab. Trametinib 1 mg Tab. Trametinib 2 mg Inj. Imiglucerase 400 units/vial Inj. Velaglucerase alpha-VPRIV 400 units Inj. Laronidase 2.9mg/5ml Inj. Idursulfase 6mg/3ml Inj. Alglucosidase Alfa 50mg Inj. Agalsidasealfa 3.5mg/3.5ml Inj. Agalsidase beta 35mg Syp. Risdiplam 60mg/80ml Cap. Nitisinone 5mg Cap. Nitisinone 10mg Cap. Trientine 333mg Inj. Complement C1 esterase inhibitor 500IU Tab. Everolimus 0.25mg Tab. Everolimus 0.5mg Tab. Everolimus 0.75mg Tab. Everolimus 5mg Tab. Everolimus 10mg Inj. Evolocumab 140mg/ml Inj. Brentuximab 50mg Tab. Tucatinib 150m |
| Published Date | |
|---|---|
| Due Date | 08 Jun 2026 16:00:00 |
| Tender Open Date |
| Estimated Value | 0.0 |
|---|---|
| EMD | 75000 INR |
| Processing Fee | 0 INR |